Skip to main content
Top
Literature
1.
go back to reference Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951CrossRefPubMed Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937–951CrossRefPubMed
2.
go back to reference Kohla AS, Sabbagh AA, Omri HE et al (2015) Mixed phenotype acute leukemia with two immunophenotypically distinct B and T blasts populations, double Ph + chromosome and complex karyotype: report of an unusual case. Clin Med Insights Blood Disord. 8:25–31CrossRefPubMedPubMedCentral Kohla AS, Sabbagh AA, Omri HE et al (2015) Mixed phenotype acute leukemia with two immunophenotypically distinct B and T blasts populations, double Ph + chromosome and complex karyotype: report of an unusual case. Clin Med Insights Blood Disord. 8:25–31CrossRefPubMedPubMedCentral
3.
go back to reference Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405CrossRefPubMed Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405CrossRefPubMed
4.
go back to reference Naghashpour M, Lancet J, Moscinski L et al (2010) Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/MLL-MLLT1(ENL), B/T-lymphoid type: A first case report. Am J Hematol 85(6):451–454PubMed Naghashpour M, Lancet J, Moscinski L et al (2010) Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/MLL-MLLT1(ENL), B/T-lymphoid type: A first case report. Am J Hematol 85(6):451–454PubMed
Metadata
Title
Diagnostic Dilemma in Ambiguous Lineage Acute Leukemia: A Case Report
Authors
Neha Singh
Dushyant Kumar
Narendra Agrawal
Ajit Panaych
Anurag Mehta
Publication date
01-01-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0802-3

Other articles of this Issue 1/2018

Indian Journal of Hematology and Blood Transfusion 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine